Skip to main content
Clinical Trials/NL-OMON48605
NL-OMON48605
Recruiting
Not Applicable

Minimally and non-invasive methods for early detection and progression of endometrial cancer - Endometrial cancer early diagnosis and prognosis

Academisch Medisch Centrum0 sites200 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Academisch Medisch Centrum
Enrollment
200
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Being older than 18 year
  • \- Diagnosis of endometrial cancer (endometrioid, serous, clear cell or mucinous; dedifferentiated; high grade or low grade)
  • \- Patients must have signed an approved informed consent;Controls:
  • \- Being older than 18 year
  • \- Being diagnosed with a benign gynaecological disease, e.g. myoma uteri, prolapsed uterus, or undergoing hysterectomy as prophylactic measure (Lynch syndrome)
  • \- Controls will be enrolled if they are\-matched with cases (benign disorders may occur more frequently than EC at young age
  • \- Subjects must have signed an approved informed consent

Exclusion Criteria

  • \- Being younger than 18 year
  • \- Diagnosis of atypical hyperplasia, other types of cancer, sarcoma uteri
  • \- Previous diagnosis of EC
  • \- Being pregnant at the moment of enrollment
  • \- Inability to approve the informed consent form;Controls:
  • \- Being younger than 18 year
  • \- Being diagnosed with a benign ovarian diseases
  • \- Being diagnosed with any malignancy
  • \- Previous diagnosis of EC
  • \- Being pregnant at the moment of enrollment

Outcomes

Primary Outcomes

Not specified

Similar Trials